India Gets First Weekly Insulin for Diabetes Patients
Novo Nordisk launched Awiqli, India's first weekly basal insulin for adults with Type 1 and Type 2 diabetes. This aims to reduce injections from 365 to 52 per year, potentially overcoming a major barrier to insulin therapy in India.













